Elea.ai

Website

Elea.ai, Inc

4 Investors
Health Technology Software
MENLO PARK, CA

Elea.ai is a German health-tech startup that develops an AI-powered Pathology Operating System to automate and streamline laboratory workflows. The platform aims to address critical inefficiencies such as staff shortages and administrative burdens, significantly reducing diagnostic turnaround times from weeks to hours. By using voice control and custom large language models, Elea.ai offers a comprehensive solution to replace outdated legacy systems in pathology.

Products & Team

Elea AI-powered Pathology Operating System

Pathology Operating SystemSeed

This is a comprehensive B2B software platform engineered to manage and automate the entire pathology workflow, from the initial order entry and sample tracking to the co-creation of the final diagnostic report. It integrates with existing laboratory equipment and hospital information systems to create a cohesive, efficient environment.

Value Proposition

The system alleviates the burdens of staff shortages, physician burnout, and overwhelming administrative tasks that cause diagnostic delays. It dramatically accelerates patient treatment by reducing the time from sample reception to final report from several weeks to just a few hours.

Pain Points

Customers face significant challenges with outdated legacy infrastructure, staff shortages leading to physician burnout, overwhelming administrative tasks, and inefficient workflows that result in long and unacceptable delays in diagnosis.

Intelligent automation of administrative and reporting tasksHands-free, voice-powered control for system commandsSeamless integration with laboratory and hospital information systems (LIS/HIS)AI-driven precision using custom-trained Large Language Models (LLMs)Complete workflow orchestration from sample intake to final report
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
MENLO PARK, CA
Primary headquarters

Funding History

Total Raised:
$9.0M
E

Equity Offering

August 2025
$10.6M
Target
Progress
85%
Raised
$9.0M
Target
$10.6M
#000208440225000001